(Q53863939)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Comparison of three PCR assays for the evaluation of interferon-beta biological activity in patients with multiple sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Fabiana Marnetto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Guglielmo Stefanuto

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Valentina Rinaldi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Federica Farinazzo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Simona Malucchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marco Capobianco

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Marzia Caldano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Arianna Sala

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Antonio Bertolotto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

Molecular Diagnosis and Therapy

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

185-194

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf03260063

9 January 2020

exact match

0 references

cites work

Persistent neutralizing antibodies abolish the interferon beta bioavailability in MS patients.

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Neutralizing antibodies reduce the efficacy of betaIFN during treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Pharmacokinetics of recombinant human interferon-beta ser in healthy volunteers and its effect on serum neopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

The human intracellular Mx-homologous protein is specifically induced by type I interferons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Neutralizing antibodies reduce MxA protein induction in interferon-beta-1a-treated MS patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Neutralizing antibodies against IFN-beta in multiple sclerosis: antagonization of IFN-beta mediated suppression of MMPs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Evaluation of bioavailability of three types of IFNbeta in multiple sclerosis patients by a new quantitative-competitive-PCR method for MxA quantification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Evaluation of IFNalpha bioavailability by MxA mRNA in HCV patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Biological activity of interferon betas in patients with multiple sclerosis is affected by treatment regimen and neutralising antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Neutralization of the biological activity of cytokines and other protein effectors by antibody: theoretical formulation of antibody titration curves in relation to antibody affinity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Increased levels of antiviral MxA protein in peripheral blood of patients with a chronic disease of unknown etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Real time quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Two variants of quantitative reverse transcriptase PCR used to show differential expression of alpha-, beta- and gamma-fibrinogen genes in rat liver lobes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03260063

Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards

21 January 2018

1 reference

12 December 2020

Standardization and quality control of PCR analyses

1 reference

12 December 2020

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

12 December 2020

Mechanisms for regulation of cellular responsiveness to human IFN-beta1a

1 reference

12 December 2020

BCR/ABL mRNA and the P210(BCR/ABL) protein are downmodulated by interferon-alpha in chronic myeloid leukemia patients

1 reference

12 December 2020

MxA Gene Expression Analysis as an Interferon-β Bioactivity Measurement in Patients with Multiple Sclerosis and the Identification of Antibody-Mediated Decreased Bioactivity

1 reference

12 December 2020

Quantitation of neutralization of interferon by antibody

1 reference

12 December 2020

Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: experience during the first three years. The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group

1 reference

12 December 2020

Pharmacodynamics of biological response in vivo after single and multiple doses of interferon-beta

1 reference

12 December 2020

Comparative study of the pharmacodynamic and pharmacologic effects of Betaseron and AVONEX.

1 reference

12 December 2020

Bioavailability of interferon beta 1b in MS patients with and without neutralizing antibodies

1 reference

12 December 2020

Mechanism(S) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis

1 reference

12 December 2020

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

1 reference

12 December 2020

The neutralization of interferons by antibody. II. Neutralizing antibody unitage and its relationship to bioassay sensitivity: the tenfold reduction unit

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03260063

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15771557%20AND%20SRC:MED&resulttype=core&format=json

release_yc27leqqvrcx3o3gstgjo2cjm4

9 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yc27leqqvrcx3o3gstgjo2cjm4

24 November 2022

mapped directly with Wikidata item

1 reference